OVID Ovid Therapeutics Inc.
$2.69▲ +2.28%
Healthcare
Other
After hours
$2.70▲ +0.26%
Sep 11, 7:30 PM ET
Volume 1.15M
Avg Volume (10D) 1.39M
Key Metrics & Fundamentals
Market Cap
$525.35M
P/E Ratio
–
Div Yield
–%
52W Range
1.12 - 3.11
% vs 50 MA
2.79%
% vs 200 MA
20.98%
RSI-14
48.9
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.27
Free Cash Flow
-$17.59M
Gross Rev
$733,000
Gross Profit
$733,000
EBITDA
-$15.68M
COGS
–
Operating Exp
$16.43M
Operating Income
-$15.70M
EBIT
-$15.70M
Pretax Income
-$15.01M
Net Income
-$15.01M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Ovid Therapeutics (OVID) Cashes In One Bet To Fund Its Next Two
Insider Monkey · Sep 12, 2026 10:46 AM
Ovid Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 3, 2026 12:00 PM
What Makes Ovid Therapeutics (OVID) a Strong Momentum Stock: Buy Now?
Zacks · Aug 18, 2026 4:00 PM
Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 13, 2026 1:50 PM
Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
GlobeNewswire · Aug 13, 2026 12:30 PM
Outlook Therapeutics, Inc. (OTLK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks · Aug 6, 2026 2:00 PM
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 6, 2026 1:50 PM
Earnings Preview: Ovid Therapeutics (OVID) Q2 Earnings Expected to Decline
Zacks · Aug 5, 2026 2:00 PM
Oppenheimer Adjusts Ovid Therapeutics Price Target to $9 From $7, Maintains Outperform Rating
MT Newswires · Aug 3, 2026 12:54 PM
Ovid Therapeutics (OVID) Appoints Kevin Norrett as Chief Business Officer
Insider Monkey · Jul 14, 2026 10:33 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See OVID's money flow as a full page
Social Sentiment
No Reddit posts found for OVID.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.